The Oncologic Safety of Sentinel Lymph Node Biopsy in Patients with Node-Positive Breast Cancer with Complete Response to Neoadjuvant Chemotherapy: A Single-Center Experience.
Ismail Can TercanYasar YildizÖzlem ÖzdemirDemet Kocatepe CavdarFunda Alkan TasliZehra Hilal AdibelliMurat KaratasCenk Şimşekİsabel Raika DurusoyAdam UsluPublished in: The breast journal (2023)
In this study, no event developed in cases with ypCR and ypNCR in the breast and axilla. The persistence of the same results in long-termfollow-ups may enable the use of ypNCR as a positive prognostic marker in addition to ypCR.